Funders · Entity Annotation Prototype (beta)

1articles mentioning funders

1funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: NCT06509984 ×

NCT06509984

This funder is selected. Its supporting articles are shown below.

NCT065099841

Articles mentioning NCT06509984

1 articles · page 1 of 1

Multicentre phase II open study assessing the efficacy and safety of apremilast in children and adults with epidermolysis bullosa simplex generalised: study protocol for the EBULO study

bmjopen · abstract · 2025-11-12 · 1 matching annotations

77.6%

French Ethical Review Authority NCT06509984 apremilast Epidermolysis bullosa EBS-sev EBULO EBS EB

…the treatment periods of the study.Ethics and dissemination The French Ethical Review Authority has approved the EBULO trial protocol. Results will be publishe…

Browse funders

NCT06509984

Articles mentioning NCT06509984

Multicentre phase II open study assessing the efficacy and safety of apremilast in children and adults with epidermolysis bullosa simplex generalised: study protocol for the EBULO study